Protein kinase Cβ inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 16, Issue 6, 2005, Pages 1654-1660

  Kelly, Darren J ^a,b   Chanty, Anna ^a   Gow, Renae M ^a   Zhang, Yuan ^a   Gilbert, Richard E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; PROTEIN KINASE C BETA; RUBOXISTAURIN; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; ENZYME INHIBITOR; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; PROTEIN KINASE C; SIALOGLYCOPROTEIN; SPP1 PROTEIN, HUMAN; SPP1 PROTEIN, RAT; TGFB1 PROTEIN, HUMAN; TGFB1 PROTEIN, RAT; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME INHIBITION; FEMALE; FIBROSING ALVEOLITIS; INTERSTITIAL NEPHRITIS; KIDNEY CORTEX; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; ANIMAL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; EVALUATION; EXPERIMENTAL DIABETES MELLITUS; KIDNEY; MACROPHAGE ACTIVATION; METABOLISM; PATHOPHYSIOLOGY;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ENZYME INHIBITORS; FEMALE; INDOLES; KIDNEY; MACROPHAGE ACTIVATION; MALEIMIDES; NEPHRITIS, INTERSTITIAL; OSTEOPONTIN; PROTEIN KINASE C; RATS; SIALOGLYCOPROTEINS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 26944448628     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2004070578     Document Type: Article

References (46)

1. Rodriguez-Iturbe B, Pons H, Herrera-Acosta J, Johnson RJ: Role of immunocompetent cells in nonimmune renal diseases. Kidney Int 59: 1626-1640, 2001
2. Jackle I, Gunther W, von Gise H, Alt JM, Bohle A, Stolte H: Kidney function and protein excretion in relation to pathomorphology of glomerular diseases. Contrib Nephrol 68: 128-135, 1988
3. Nikolic-Paterson DJ, Atkins RC: The role of macrophages in glomerulonephritis. Nephrol Dial Transplant 16[Suppl 5]: 3-7, 2001
4. Wu L, Cox A, Roe C, Dziadek M, Cooper ME, Gilbert RE: Transforming growth factor beta1 and renal injury following subtotal nephrectomy in the rat: Role of the reninangiotensin system. Kidney Int 51: 1553-1567, 1997
5. Panzer U, Thaiss F, Zahner G, Barth P, Reszka M, Reinking RR, Wolf G, Helmchen U, Stahl RA: Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 59: 1762-1769, 2001
6. Takemoto M, Yokote K, Yamazaki M, Ridall AL, Butler WT, Matsumoto T, Tamura K, Saito Y, Mori S: Enhanced expression of osteopontin by high glucose. Involvement of osteopontin in diabetic macroangiopathy. Ann N Y Acad Sci 902: 357-363, 2000
7. Sodhi CP, Batlle D, Sahai A: Osteopontin mediates hypoxia-induced proliferation of cultured mesangial cells: role of PKC and p38 MAPK. Kidney Int 58: 691-700, 2000
8. Beck GR Jr, Knecht N: Osteopontin regulation by inorganic phosphate is ERK1/2-, protein kinase C-, and proteasome-dependent. J Biol Chem 278: 41921-41929, 2003
9. Kelly DJ, Wilkinson-Berka JL, Allen TJ, Cooper ME, Skinner SL: A new model of diabetic nephropathy with progressive renal impairment in the transgenic (mRen-2)27 rat. Kidney Int 54: 343-352, 1998
10. Kelly DJ, Wilkinson-Berka JL, Ricardo SD, Cox AJ, Gilbert RE: Osteopontin expression and macrophage accumulation in advanced diabetic nephropathy. Nephrol Dial Transplant 17: 1-7, 2002
11. Yu HC, Burrell LM, Black MJ, Wu LL, Dilley RJ, Cooper ME, Johnston CI: Salt induces myocardial and renal fibrosis in normotensive and hypertensive rats. Circulation 98: 2621-2628, 1998
12. Kelly DJ, Cox AJ, Gow RM, Zhang Y, Kemp BE, Gilbert RE: Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 44: 195-202, 2004
13. Lehr HA, Mankoff DA, Corwin D, Santeusanio G, Gown AM: Application of Photoshop-based image analysis to quantification of hormone receptor expression in breast cancer. J Histochem Cytochem 45: 1559-1565, 1997
14. Lehr HA, van der Loos CM, Teeling P, Gown AM: Complete chromogen separation and analysis in double immunohistochemical stains using Photoshop-based image analysis. J Histochem Cytochem 47: 119-126, 1999
15. Jones SE, Kelly DJ, Cox AJ, Zhang Y, Gow RM, Gilbert RE: Mast cell infiltration and chemokine expression in progressive renal disease. Kidney Int 64: 906-913, 2003
16. Kelly DJ, Cox AJ, Gow RM, Zhang Y, Kemp BE, Gilbert RE: Platelet-derived growth factor receptor transactivation mediates the trophic effects of angiotensin II in vivo. Hypertension 44: 194-202, 2004
17. Koya D, Jirousek MR, You-Wei L, Ishii H, Kuboki K, King GL: Characterization of protein kinase C beta isoform activation on gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 100:115-126, 1997
18. Murphy M, McGinty A, Godson C: Protein kinases C: Potential targets for intervention in diabetic nephropathy. Curr Opin Nephrol Hypertens 7: 563-570, 1998
19. Koya D, King GL: Protein kinase C activation and the development of diabetic complications. Diabetes 47: 859-866, 1998
20. Ishii H, Jirousek MR, Koya D, Takagi C, Xia P, Clermont A, Bursell S-E, Kern TS, Ballas LM, Heath WF, Stramm LE, Feener EP, King GL: Amelioration of vascular dysfunction in diabetic rats by an oral PKC beta inhibitor. Science 272: 728-731, 1996
21. Goekjian PG, Jirousek MR: Protein kinase C in the treatment of disease: Signal transduction pathways, inhibitors, and agents in development. Curr Med Chem 6: 877-903, 1999
22. Aiello LP: The potential role of PKC beta in diabetic retinopathy and macular edema. Surv Ophthalmol 47[Suppl 2]: S263-S269, 2002
23. Kim H, Sasaki T, Maeda K, Koya D, Kashiwagi A, Yasuda H: Protein kinase Cbeta selective inhibitor LY333531 attenuates diabetic hyperalgesia through ameliorating cGMP level of dorsal root ganglion neurons. Diabetes 52: 2102-2109, 2003
24. Beckman JA, Goldfine AB, Gordon MB, Garrett LA, Creager MA: Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humans. Circ Res 90: 107-111, 2002
25. Turtle KR, Anderson PW: A novel potential therapy for diabetic nephropathy and vascular complications: Protein kinase C beta inhibition. Am J Kidney Dis 42: 456-465, 2003
26. Koya D, Haneda M, Nakagawa H, Isshiki K, Sato H, Maeda S, Sugimoto T, Yasuda H, Kashiwagi A, Ways DK, King GL, Kikkawa R: Amelioration of accelerated diabetic mesangial expansion by treatment with a PKC beta inhibitor in diabetic db/db mice, a rodent model for type 2 diabetes. FASEB J 14: 439-447, 2000
27. Gilbert RE, Cooper ME: The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury? Kidney Int 56: 1627-1637, 1999
28. Alexopoulos E, Seron D, Hartley RB, Cameron JS: Lupus nephritis: Correlation of interstitial cells with glomerular function. Kidney Int 37: 100-109, 1990
29. Hooke DH, Gee DC, Atkins RL: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31: 964-972, 1987
30. Sabadini E, Castiglione A, Colasanti G, Ferrario F, Civardi R, Fellin G, D'Amico G: Characterization of interstitial infiltrating cells in Berger's disease. Am J Kidney Dis 12:307-315, 1988
31. Border WA, Brees D, Noble NA: Transforming growth factor-beta and extracellular matrix deposition in the kidney. Contrib Nephrol 107: 140-145, 1994
32. Furuta T, Saito T, Ootaka T, Soma J, Obara K, Abe K, Yoshinaga K: The role of macrophages in diabetic glomerulosclerosis. Am J Kidney Dis 21: 480-485, 1993
33. Young BA, Johnson RJ, Alpers CE, Eng E, Gordon K, Floege J, Couser WG, Seidel K: Cellular events in the evolution of experimental diabetic nephropathy. Kidney Int 47: 935-944, 1995
34. Giachelli CM, Lombardi D, Johnson RJ, Murry CE, Almeida M: Evidence for a role of osteopontin in macrophage infiltration in response to pathological stimuli in vivo. Am J Pathol 152: 353-358, 1998
35. Ophascharoensuk V, Giachelli CM, Gordon K, Hughes J, Fichier R, Brown P, Liaw L, Schmidt R, Shankland SJ, Alpers CE, Couser WG, Johnson RJ: Obstructive uropathy in the mouse: Role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 56: 571-580, 1999
36. Mazzali M, Hughes J, Dantas M, Liaw L, Steitz S, Alpers CE, Fichier RH, Lan HY, Giachelli CM, Shankland SJ, Couser WG, Johnson RJ: Effects of cyclosporine in osteopontin null mice. Kidney Int 62: 78-85, 2002
37. Kawamura H, Yokote K, Asaumi S, Kobayashi K, Fujimoto M, Maezawa Y, Saito Y, Mori S: High glucose-induced upregulation of osteopontin is mediated via Rho/Rho kinase pathway in cultured rat aortic smooth muscle cells. Arterioscler Thromb Vasc Biol 24: 276-281, 2004
38. Hsieh T-J, Chen R, Ingelfinger JR, Whiteside CI, Fantus IG, Chan JSD: Osteopontin mRNA is differentially upregulated in diabetic rat renal proximal tubular cells revealed by DNA chip microarray: Regulation by protein kinase C-beta 1 and transforming growth factor-betal [Abstract]. J Am Soc Nephrol 15: 652, 2004
39. Mifsud S, Kelly DJ, Qi W, Zhang Y, Pollock CA, Wilkinson-Berka JL, Gilbert RE: Intervention with tranilast attenuates renal pathology and albuminuria in advanced experimental diabetic nephropathy. Nephron Physiol 95: 83-91, 2003
40. Gilbert RE, Cox A, Wu LL, Allen TJ, Hulthen L, Jerums G, Cooper ME: Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of angiotensin converting enzyme inhibition. Diabetes 47: 414-422, 1998
41. Ziyadeh FN: Role of transforming growth factor beta in diabetic nephropathy. Exp Nephrol 2: 137, 1994
42. Yamaguchi Y, Mann DM, Ruoslahti E: Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature 346: 281-284, 1990
43. O'Connor-McCourt MD, Wakefield LM: Latent transforming growth factor beta in serum. J Biol Chem 262: 14090-14099, 1987
44. Nakao A, Roijer E, Imamura T, Souchelnytskyi S, Stenman G, Heldin CH, ten Dijke P: Identification of Smad2, a human Mad-related protein in the transforming growth factor beta signaling pathway. J Biol Chem 272: 2896-2900, 1997
45. Massague J, Chen YG: Controlling TGF-beta signaling. Genes Dev 14: 627-644, 2000
46. Kelly DJ, Hepper C, Zhang Y, Jaworski K, Wilkinson-Berka JL, Gilbert RE: Protein kinase C beta inhibition attenuates the progression of experimental diabetic nephropathy in the presence of continued hypertension. Diabetes 52: 512-518, 2003